Journal of Bone Oncology

Papers
(The H4-Index of Journal of Bone Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms133
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma52
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches51
Single Photon Emission Computed Tomography/X-ray Computed Tomography-based radiomics analysis for diagnosis of bone metastases in patients with breast cancer31
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States27
Macrophage heterogeneity in bone metastasis24
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p23
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw22
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets20
Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways20
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study20
Rotationplasty performed in adults versus minors: a comparative study of long-term quality of life, functional and biomechanical outcomes19
Predicting lung metastasis in high-grade osteosarcoma: The role of computed tomography angiography (CTA) signs with a focus on vascular wrapping and the intratumoral vascular network19
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors19
State-of-the-art of minimally invasive treatments of bone metastases19
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer17
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study17
0.041556119918823